Page 9 - IJB-10-5
P. 9

International

                                                                         Journal of Bioprinting



                                        REVIEW ARTICLE
                                        Advancements in 3D bioprinting for nanoparticle

                                        evaluation: Techniques, models, and biological
                                        applications



                                        Moon Sup Yoon , Jae Min Lee , Min Jeong Jo , Su Jeong Kang ,
                                                                                             1
                                                                               2
                                                     1†
                                                                 1†
                                        Myeong Kyun Yoo , So Yeon Park , Ji-Hyun Kang , Chan-Su Park 1 id ,
                                                                    1
                                                       1
                                                                                 3
                                        Chun-Woong Park 1 id , Jin-Seok Kim , Andrea Bernardos 5,6,7,8 id ,
                                                                      4
                                        Vicente Martí-Centelles 5,6,8 id               5,6,7,8,9 id
                                                               * , Ramón Martínez-Máñez
                                                                                           * ,
                                        and Dae Hwan Shin 1,5,10*
                                        1  College of Pharmacy, Chungbuk National University, 28160 Cheongju, Republic of Korea
                                        2  Department of Oncology Science, University of Oklahoma, Oklahoma City, 73104 Oklahoma,
                                        United States of America
                                        3  Institute of New Drug Development and Respiratory Drug Development Research Institute, School
                                        of Pharmacy, Jeonbuk National University, 54896 Jeonju, Republic of Korea
                                        4  Drug Information Research Institute (DIRI), College of Pharmacy, Sookmyung Women’s University,
                                        04310 Seoul, Republic of Korea
                                        5  Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico
                                        (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n, 46022
                                        Valencia, Spain
            † These authors contributed equally   6  CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos
            to this work.               III, 46026 Madrid, Spain
            *Corresponding authors:     7  Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina,
            Vicente Martí-Centelles     Universitat Politècnica de València, Centro de Investigación Príncipe Felipe, Avenida Eduardo
            (vimarce1@upv.es)           Primo Yúfera, 3, 46012 Valencia, Spain
            Ramón Martínez-Máñez        8  Departamento  de  Química,  Universitat  Politècnica  de  València,  Camino  de  Vera  s/n,  46022
            (rmaez@qim.upv.es)          Valencia, Spain
            Dae Hwan Shin               9  Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València,
            (dshin@chungbuk.ac.kr)      Instituto de Investigación Sanitaria La Fe (IISLAFE), Avenida Fernando Abril Martorell, 106, 46026
            Citation: Yoon MS, Lee JM,   Valencia, Spain
            Jo MJ, et al. Advancements in   10   Chungbuk  National  University  Hospital,  Chungbuk  National  University,  28644  Cheongju,
            3D bioprinting for nanoparticle   Republic of Korea
            evaluation: Techniques, models,
            and biological applications.    (This article belongs to the Special Issue: Advances in Bioprinting and Organ-on-a-chip and Applications for
            Int J Bioprint. 2024;10(5):4273.    Precision Medicine)
            doi: 10.36922/ijb.4273
            Received: July 17, 2024     Abstract
            Revised: August 6, 2024
            Accepted: August 7, 2024
            Published Online: August 9, 2024  Three-dimensional (3D) bioprinting technology has opened new possibilities for
                                        nanoparticle evaluation.  This review discusses the latest research trends using
            Copyright: © 2024 Author(s).
            This is an Open Access article   various disease models created through 3D bioprinting for the biological evaluation
            distributed under the terms of the   of nanoparticles. The focus is on tumor models, vascular models, and skin models. In
            Creative Commons Attribution   tumor models, evaluations include antitumor effects, gene expression analysis, and
            License, permitting distribution,
            and reproduction in any medium,   cytotoxicity comparisons between 2D and 3D models. Vascular models are used to
            provided the original work is   assess restenosis prevention, ischemic repair, and vascular regeneration. Skin models
            properly cited.             are employed to investigate nanoparticle toxicity, drug release, and transdermal
            Publisher’s Note: AccScience   penetration. These studies highlight the versatility of 3D bioprinting in replicating
            Publishing remains neutral with   complex biological environments, enabling more accurate nanoparticle testing. The
            regard to jurisdictional claims in
            published maps and institutional   use of various bioinks and cell types enhances the relevance of in vitro findings. The
            affiliations.               integration of nanoparticles with 3D-bioprinted models shows significant potential


            Volume 10 Issue 5 (2024)                        1                                 doi: 10.36922/ijb.4273
   4   5   6   7   8   9   10   11   12   13   14